Vaccine Development

Clinical Trials Vaccine Research mRNA Technology Farm Worker Protection Manufacturing Monitoring Variants Vaccine Production Research Studies Vaccine Efficacy COVID-19 Vaccine Manufacturers Funding and Research Broad-Spectrum Protection Tuberculosis Vaccines MMR Vaccine Fetal Cell Lines Vaccine Distribution Epitopes Types of Vaccines Viral Infections Funding Phase Studies Therapeutic Vaccines Infectious Disease Preparedness Research Institutions Public Health Viral Diseases Experimental Treatments Vaccine Candidates

DRC Begins Vaccinating Health Workers with Zaire Vaccine as Bundibugyo Outbreak Expands

The trial will test whether the only widely available Ebola vaccine protects health workers, guiding urgent development of vaccines that target the Bundibugyo strain.

Hilleman Laboratories to Produce rVSV Bundibugyo Ebola Vaccine Doses for Early Trials

Oxford Administers First Human Dose of Bundibugyo Ebola Vaccine

WHO, Gavi and UNICEF Restart Preventive Cholera Vaccinations With 20 Million Doses

AI-Powered Pipeline Identifies Conserved T-Cell Targets for Universal Coronavirus Vaccines

Ragon Institute Identifies Antibody Features That Restrain Tuberculosis Bacteria